Profile and Area of Expertise
Dr. Vimal Narayanan is an experienced Siddha physician in Banglore, India. He has 13 years of experience in this field. The Siddha system of medicine is primarily practiced in parts of southern India. It is one of the world’s oldest traditional medicine systems, treating not only the physical body but also the mind and soul. He was the co-investigator for these projects A Prospective, double-blind, randomized clinical study to evaluate the antibody response after the COVID-19 vaccine when provided with NOQ19 Ayurvedic medicine, AIIMS, New Delhi ( Ongoing Project), A Randomized Controlled Double-Blinded Comparative Clinical Trial to Evaluate the effectiveness of Siddha medicines along with standard Allopathy treatment in the management of symptomatic COVID 19 patients, SCRU-GIMS, NOIDA 2020 (Completed).
A randomized, double blind, placebo controlled, multi-centric, trial to determine the therapeutic efficacy of Ayush medicine NF2 in treatment of symptomatic COVID-19 patients along with standard allopathic treatment (Ongoing), An Open labeled RCT to Evaluate the Efficacy and Safety of Siddha Supplement (MAM Granules) along with Standard Allopathy Treatment in the management of RT PCR Positive Pre Symptomatic COVID 19 patients(Completed), Evaluation of efficacy and safety of two Siddha formulations for the treatment of functional Constipation – A Comparative Randomized Clinical Trial, and also he worked as the coordinator for so many projects like Population study for COVID19 and open labeled RCT with Kabasura Kudineer tablet by SCRU-CCRS, Safdarjung hospital, New Delhi 2020, Population study for COVID19 and open labeled RCT with Kabasura Kudineer tablet( Sri Sri) by Ministry of AYUSH and
SCRU-CCRS, Safdarjung hospital, New Delhi 2021, COVID19 Medical Camps in Delhi NCR, Preventive Siddha Medicine Distribution in Delhi NCR 2020, Prevention Healthcare Program conducted by Santhigiri in association with Ministry of Health and Family Welfare, Govt. of Rajasthan at Alwar Dist, Rajasthan Project coordinator 2019, Karunya Siddha Grama Project funded by the Ministry of AYUSH, Govt. of India at Kodathi Village, Bangalore and Chandiroor, Kerala. Worked as a Senior Research Fellow In vitro and in vivo evaluation of the therapeutic potential of Siddha drugs upon Chikungunya virus infection funded by the Ministry of AYUSH, Govt. of India at International Center for Genetic Engineering and Biotechnology, New Delhi, India- 2018.
Experience (Current Position & Previous Positions)
Current Position:
- Dr.Vimal Narayanan is working as a Senior Medical Research Officer at Santhigiri Ayurveda & Siddha Hospital, Bangalore.
Previous Positions:
- Worked as a Scientist at Sri Sri Institute For Advanced Research, Bangalore (Oct 2021-Sep 2022)
- Worked as a Consultant, in the Pharmacovigilance Program in Siddha Clinical Research Unit(SCRU), CCRS, Ministry of AYUSH, Safdarjung Hospital, New Delhi (Oct 2019 – Sep 2021)
- Worked as a Project Coordinator, Public Health Awareness Programmer in SHRO & MOHFW, Govt. of Rajasthan, Alwar (Aug 2018 – Sep 2019)
- Worked as a Senior Research Fellow at International Center For Genetic Engineering & Biotechnology (ICGEB), (UN Institute), Jawaharlal Nehru University(JNU), New Delhi (Feb 2016 – Jun 2018)
- Worked as a Regional Manager in Santhigiri Healthcare & Research Organization, Bangalore (Oct 2014 – Jan 2016)
- Worked as a Medical Officer & Administrator in Santhigiri Healthcare & Research Organization, Bangalore (Oct 2009 – Jul 2011)
- Worked as a Technical Officer in Santhigiri Ayurveda & Siddha Manufacturing Unit (Feb 2009 – Oct 2009).
Education & Certificates
- Ph.D. in Immunology (Pursuing) from Amity Institute of Virology and Immunology, AMITY University, Noida (Jan 2018 -2024)
- MSc PhytoMedical Science and Technology from Mahatma Gandhi University, Kottayam (Jul 2011 – May 2014)
- BSMS from Santhigiri Siddha Medical College, University of Kerala Bachelor of Siddha Medicine and Surgery (Jun 2002 – April 2008)
Awards
- AYUSH Excellence Award for Outstanding Contribution in COVID Management Nominated by Central Council for Research in Siddha, Ministry Of Ayush by WTCC and GOTO, Dec 2020
Publications & Presentations
- Vathasura Kudineer, an Andrographis-based polyherbal formulation exhibits immunomodulation and inhibits chikungunya virus (CHIKV) under in-vitro conditions, Journal of Ethnopharmacology, Sep 2022
- Anti-inflammatory effect of Kaba Sura Kudineer (AYUSH approved COVID-19 drug)-A Siddha poly-herbal formulation against lipo-polysaccharide induced inflammatory response in RAW-264.7 macrophages cells, Journal of Ethno-pharmacology, Oct 2021
- Efficacy of Two Siddha Poly herbal Decoctions, Nilavembu Kudineer, and Kaba Sura Kudineer, along with Standard Allopathy Treatment in the Management of Mild to Moderate Symptomatic COVID-19 Patients -A Double-Blind, Placebo-Controlled, Clinical Trial, BMC, Trials 2021
- An Open labeled RCT to Evaluate the Efficacy and Safety of Siddha Supplement (MAM Granules) along with Standard Allopathy Treatment in the management of RT PCR Positive Pre Symptomatic COVID 19 patients –A Structured Summary of A Study Protocol, International Journal of Case Studies in Clinical Research 2021
- A Double Blinded Placebo Controlled Comparative Clinical Trial to Evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer(NVK) along with standard Allopathy treatment in the management of symptomatic COVID-19 patients – A structured summary of the study protocol, BMC, Trials 2021.
- Chikungunya Outbreaks In India – A Prospective Study Comparing Neutralization And Sequelae During Two Outbreaks In 2010 And 2016. American Journal Of Tropical Medicine & Hygiene 2020.
- Establishment and comparison of pathogenicity and related neurotropism in two age groups of immune-competent mice, C57BL/6J using an Indian isolate of chikungunya virus (CHIKV). Viruses.2019.
- In-vitro evaluation of the anti-viral activity of ethanol extract of Nilavembu Kudineer against Dengue and chikungunya virus infection. Journal of Ayurveda and Integrative Medicine. 2019.
- Invivo evaluation of Withania somnifera-based Indian traditional formulation (Amukkara Choornam), against chikungunya virus-induced arthralgia. Journal of evidence-based Integrated medicine 2018
Memberships
- Update Coming Soon
Languages
- English, Hindi, Kannada, Malayalam, Tamil
